Fetal fraction is the percentage of cell-free DNA in your blood that comes from the placenta (and represents your baby) rather than from your own cells. When you get a Natera Panorama test or any other noninvasive prenatal screening, this number determines whether the lab can give you a reliable result. A typical sample has a fetal fraction around 9 to 10%, and most labs need at least 2.8 to 4% to issue a call.
How Fetal Fraction Works
During pregnancy, tiny fragments of DNA from the placenta continuously shed into your bloodstream, mixing with your own cell-free DNA. Fetal fraction is simply the ratio of that placental DNA to the total. The formula is straightforward: fetal DNA divided by fetal DNA plus maternal DNA.
This ratio matters because prenatal screening works by detecting small statistical differences in chromosome counts. If you’re carrying a baby with an extra copy of chromosome 21 (Down syndrome), for example, the test looks for a slight excess of chromosome 21 material in your blood. The higher the fetal fraction, the easier that excess is to detect. With a higher percentage, there’s greater statistical separation between a pregnancy with a chromosomal difference and one without, which gives the lab more confidence in the result.
What Natera Panorama Measures
Natera’s Panorama test uses a technology based on single nucleotide polymorphisms, or SNPs. These are natural genetic variations scattered across the genome. By analyzing thousands of these tiny markers, the test can distinguish which DNA fragments belong to the placenta and which belong to you. This approach lets Panorama calculate a precise fetal fraction for each sample and use that number as a quality check before reporting results.
Your fetal fraction will appear on your results report. In studies of similar SNP-based platforms, the median fetal fraction for samples that received a successful result was about 9.1%. Samples that failed to produce a result had a median of just 3.1%.
Why Low Fetal Fraction Leads to “No-Call” Results
When fetal fraction falls below the lab’s minimum threshold, the test cannot reliably distinguish chromosomal differences from normal statistical noise. Instead of guessing, the lab issues a “no-call,” meaning no result. This happens in roughly 3% of samples.
A no-call is not a positive or negative result. It simply means the sample didn’t contain enough placental DNA to analyze. If this happens, a second blood draw a few weeks later succeeds about 78% of the time, because fetal fraction naturally rises as pregnancy progresses. In some cases the test is repeated more than once. For the small number of people whose redraws still don’t produce a result, providers may recommend diagnostic testing like amniocentesis or chorionic villus sampling instead.
Low Fetal Fraction Can Signal Higher Risk
A no-call result deserves more attention than a simple “try again.” Low fetal fraction is itself associated with a higher rate of chromosomal abnormalities. One large study found that women with a fetal fraction below 4% had an aneuploidy rate of 4.7%, compared to just 0.4% in the overall study population. Some smaller studies have reported aneuploidy rates as high as 30% in low fetal fraction groups. The likely explanation is that pregnancies affected by certain chromosomal conditions, particularly trisomy 13, trisomy 18, and triploidy, often have smaller or abnormally functioning placentas that release less DNA into the mother’s blood.
This doesn’t mean a no-call result means something is wrong. Most redraws come back low-risk. But it does mean a no-call shouldn’t be dismissed or treated as equivalent to a normal result.
What Affects Your Fetal Fraction
Several factors influence how much placental DNA is circulating in your blood at the time of the draw.
- Gestational age: Fetal fraction rises as pregnancy advances, but the rate of increase isn’t steady. Between 10 and 12.5 weeks it climbs about 0.44% per week. From 12.5 to 20 weeks, the increase slows to roughly 0.08% per week. After 20 weeks it picks up again at about 0.82% per week. This is why most providers recommend the test at 10 weeks or later, and why waiting a couple of weeks before a redraw often solves a low fetal fraction problem.
- Maternal weight: Higher body mass index is the most common reason for low fetal fraction. The mechanism is twofold. Fat tissue naturally breaks down and releases its own DNA into the bloodstream, which dilutes the relative proportion of placental DNA. On top of that, a larger blood volume can further reduce the concentration of fetal fragments in any given sample.
- Placental size and health: Conditions that affect how the placenta develops, including certain chromosomal abnormalities, can reduce the amount of DNA it sheds. This is the connection between low fetal fraction and higher aneuploidy rates discussed above.
What Your Fetal Fraction Number Means on Your Report
When you receive your Panorama results, you’ll see the fetal fraction listed as a percentage. A number in the range of 5 to 15% is common and means the lab had plenty of material to work with. Higher is better for accuracy, but anything above the minimum threshold is considered adequate for a reliable screen.
If your fetal fraction is on the lower end but still above the cutoff, the test can still provide a result, though the statistical confidence may be slightly lower than for a sample with a very high fetal fraction. The lab’s algorithms account for this when calculating risk scores.
If your number falls below the threshold and you get a no-call, the most common next step is a redraw in two to three weeks. The additional gestational time typically raises fetal fraction enough to get a result. For people with a high BMI, the increase may be slower, and your provider may discuss whether waiting longer or moving directly to diagnostic testing makes more sense for your situation.
Regardless of the fetal fraction or the result, NIPT including Panorama is a screening test, not a diagnosis. A high-risk result needs confirmation through amniocentesis or chorionic villus sampling before any clinical decisions are made.